Jennifer Petter

Founder & Chief Innovation Officer

Jennifer Petter, Ph.D., is a Founder & Chief Innovation Officer of Arrakis Therapeutics. An experienced drug hunter, scientist, and life science executive, Dr. Petter’s research has spanned different fields over the years, with a current focus on RNA at Arrakis. She is the author or co-author of over 50 papers and over 50 patents and/or patent applications. Prior to creating Arrakis, Dr. Petter was Vice President of Chemistry at Celgene. She joined Celgene after the acquisition of Avila Therapeutics, a startup, in 2012. She has also held roles at Mersana Therapeutics, Biogen, and the Sandoz Research Institute (now a part of Novartis). Dr. Petter received her bachelor’s degree from Dartmouth College and her Ph.D. from Duke University. She completed her post-doctorate research at Columbia University.

Talks About
#innovation #management

Preferred Locations
#Northamerica